Le SIDA en Afrique subsaharienne (serveur d'exploration) - Checkpoint (Ncbi)

Index « Mesh.i » - entrée « Drug Administration Schedule »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Drug Administration Routes < Drug Administration Schedule < Drug Approval  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]
Ident.Authors (with country if any)Title
000571 (2008) Andrew Prendergast [Royaume-Uni] ; Wendy Mphatswe ; Gareth Tudor-Williams ; Mpho Rakgotho ; Visva Pillay ; Christina Thobakgale ; Noel Mccarthy ; Lynn Morris ; Bruce D. Walker ; Philip GoulderEarly virological suppression with three-class antiretroviral therapy in HIV-infected African infants.
000943 (2010) Patricia L. Toro [États-Unis] ; Monica Katyal ; Rosalind J. Carter ; Landon Myer ; Wafaa M. El-Sadr ; Denis Nash ; Elaine J. AbramsInitiation of antiretroviral therapy among pregnant women in resource-limited countries: CD4+ cell count response and program retention.
000A63 (2010) Salim S. Abdool Karim [Afrique du Sud] ; Kogieleum Naidoo ; Anneke Grobler ; Nesri Padayatchi ; Cheryl Baxter ; Andrew Gray ; Tanuja Gengiah ; Gonasagrie Nair ; Sheila Bamber ; Aarthi Singh ; Munira Khan ; Jacqueline Pienaar ; Wafaa El-Sadr ; Gerald Friedland ; Quarraisha Abdool KarimTiming of initiation of antiretroviral drugs during tuberculosis therapy.
000C15 (2010) Jean B. Nachega [États-Unis] ; Richard E. Chaisson ; Rene Goliath ; Anne Efron ; Mohammad A. Chaudhary ; Malathi Ram ; Chelsea Morroni ; Hennie Schoeman ; Amy R. Knowlton ; Gary MaartensRandomized controlled trial of trained patient-nominated treatment supporters providing partial directly observed antiretroviral therapy.
000C19 (2010) Roland Landman [France] ; M B Diallo ; N F Ngom Gueye ; C Toure Kane ; S. Mboup ; M B Koita Fall ; B. Ndiaye ; G. Peytavin ; Y. Bennai ; A. Benalycherif ; P M Girard ; P S SowEfficacy and safety of unboosted atazanavir in combination with lamivudine and didanosine in naive HIV type 1 patients in Senegal.
000C31 (2010) Jon CohenAIDS research. Bioethicists assail a celebrated TB/HIV treatment trial.
000C46 (2010) Christopher J. Hoffmann [Afrique du Sud] ; Katherine L. Fielding ; Salome Charalambous ; Craig Innes ; Richard E. Chaisson ; Alison D. Grant ; Gavin J. ChurchyardReducing mortality with cotrimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa.
000C92 (2010) Eugene Athan [Australie] ; Daniel P. O'Brien ; Rosa LegoodCost-effectiveness of routine and low-cost CD4 T-cell count compared with WHO clinical staging of HIV to guide initiation of antiretroviral therapy in resource-limited settings.
000D01 (2010) Doaa Elsherbiny [Suède] ; Yuan Ren ; Helen Mcilleron ; Gary Maartens ; Ulrika S H. SimonssonPopulation pharmacokinetics of lopinavir in combination with rifampicin-based antitubercular treatment in HIV-infected South African children.
000D16 (2010) Marcel Yotebieng [États-Unis] ; Annelies Van Rie ; Harry Moultrie ; Stephen R. Cole ; Adaora Adimora ; Frieda Behets ; Tammy MeyersEffect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment.
000D46 (2010) Candace M. Miller [États-Unis] ; Mpefe Ketlhapile ; Heather Rybasack-Smith ; Sydney RosenWhy are antiretroviral treatment patients lost to follow-up? A qualitative study from South Africa.
000D69 (2010) Matthew P. Fox [États-Unis] ; Ian M. Sanne ; Francesca Conradie ; Jennifer Zeinecker ; Catherine Orrell ; Prudence Ive ; Mohammed Rassool ; Marjorie Dehlinger ; Charles Van Der Horst ; James Mcintyre ; Robin WoodInitiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa.
001946 (2012) Kevin Peterson [Belgique] ; Toyin Togun ; Sandor Klis ; Joris Menten ; Robert ColebundersDepression and posttraumatic stress disorder among HIV-infected Gambians on antiretroviral therapy.
001A35 (2013) S M Le Roux [Afrique du Sud] ; M F Cotton ; L. Myer ; D M Le Roux ; H S Schaaf ; C J Lombard ; H J ZarSafety of long-term isoniazid preventive therapy in children with HIV: a comparison of two dosing schedules.
001A76 (2013) Kogieleum Naidoo [Afrique du Sud] ; Cheryl Baxter ; Salim S. Abdool KarimWhen to start antiretroviral therapy during tuberculosis treatment?
002114 (2013) D Heather Watts [États-Unis] ; Elizabeth R. Brown ; Yvonne Maldonado ; Casey Herron ; Tsungai Chipato ; Leanne Reddy ; Dhayendre Moodley ; Clemensia Nakabiito ; Karim Manji ; Wafaie Fawzi ; Kathleen George ; Paul Richardson ; Sheryl Zwerski ; Hoosen Coovadia ; Maryglenn FowlerHIV disease progression in the first year after delivery among African women followed in the HPTN 046 clinical trial.
002523 (2013) Michael Schomaker [Afrique du Sud] ; Matthias Egger ; James Ndirangu ; Sam Phiri ; Harry Moultrie ; Karl Technau ; Vivian Cox ; Janet Giddy ; Cleophas Chimbetete ; Robin Wood ; Thomas Gsponer ; Carolyn Bolton Moore ; Helena Rabie ; Brian Eley ; Lulu Muhe ; Martina Penazzato ; Shaffiq Essajee ; Olivia Keiser ; Mary-Ann DaviesWhen to start antiretroviral therapy in children aged 2-5 years: a collaborative causal modelling analysis of cohort studies from southern Africa.
002A95 (2014) Adegoke O. Adefolalu [Oman] ; Zerish Z. Nkosi [Afrique du Sud] ; Steve A S. Olorunju [Afrique du Sud]Patterns of adherence to scheduling and dietary instructions among patients on antiretroviral therapy in Pretoria, South Africa.
003894 (2016) Sylvie Boyer [France] ; Collins Iwuji [Afrique du Sud] ; Andréa Gosset [France] ; Camelia Protopopescu [France] ; Nonhlanhla Okesola [Afrique du Sud] ; Mélanie Plazy [France] ; Bruno Spire [France] ; Joanna Orne-Gliemann [France] ; Nuala Mcgrath [Afrique du Sud] ; Deenan Pillay [Afrique du Sud] ; François Dabis [France] ; Joseph Larmarange [Afrique du Sud]Factors associated with antiretroviral treatment initiation amongst HIV-positive individuals linked to care within a universal test and treat programme: early findings of the ANRS 12249 TasP trial in rural South Africa.
003B48 (2017) Olalekan A. Uthman [Afrique du Sud] ; Jean B. Nachega [États-Unis] ; Jean Anderson [États-Unis] ; Steve Kanters [Canada] ; Edward J. Mills [Canada] ; Françoise Renaud [Suisse] ; Shaffiq Essajee [Suisse] ; Meg C. Doherty [Suisse] ; Lynne M. Mofenson [États-Unis]Timing of initiation of antiretroviral therapy and adverse pregnancy outcomes: a systematic review and meta-analysis.
003C48 (2017) Jemma O'Connor [Royaume-Uni] ; Michael J. Vjecha [États-Unis] ; Andrew N. Phillips [Royaume-Uni] ; Brian Angus [Royaume-Uni] ; David Cooper [Australie] ; Beatriz Grinsztejn [Brésil] ; Gustavo Lopardo [Argentine] ; Satyajit Das [Royaume-Uni] ; Robin Wood [Afrique du Sud] ; Aimee Wilkin [États-Unis] ; Hartwig Klinker [Allemagne] ; Pacharee Kantipong [Thaïlande] ; Karin L. Klingman [États-Unis] ; David Jilich [République tchèque] ; Elbushra Herieka [Royaume-Uni] ; Eileen Denning [États-Unis] ; Ibrahim Abubakar [Royaume-Uni] ; Fred Gordin [États-Unis] ; Jens D. Lundgren [Danemark]Effect of immediate initiation of antiretroviral therapy on risk of severe bacterial infections in HIV-positive people with CD4 cell counts of more than 500 cells per μL: secondary outcome results from a randomised controlled trial.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/SidaSubSaharaV1/Data/Ncbi/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i -k "Drug Administration Schedule" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Mesh.i  \
                -Sk "Drug Administration Schedule" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    SidaSubSaharaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Drug Administration Schedule
}}

Wicri

This area was generated with Dilib version V0.6.32.
Data generation: Mon Nov 13 19:31:10 2017. Site generation: Wed Mar 6 19:14:32 2024